Joshi Acosta - Concepedia

Author

Joshi Acosta

Hospital Universitario 12 De Octubre ORCID

Also Known As

J. Acosta, J.R.M. Acosta Barriga, Joshi Acosta

Publications

527

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario 12 De Octubre Complexo Hospitalario Universitario A Coruña University of the Basque Country

About

Joshi Acosta is an author at Hospital Universitario 12 De Octubre specializing in medicine, microbiology, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	446
2	Microbiology	5	5	326
3	Health Sciences	4	4	279
4	Epidemiology	2	2	70
5	Medical Laboratory Science	2	2	120

Joshi Acosta

Publications

485

Citations

H-Index

Page 1

	Year	Citations
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 <i>Pseudomonas aeruginosa</i> Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain Esther Viedma, Carlos Juan, Joshi Acosta, Antimicrobial Agents and Chemotherapy Pseudomonas Aeruginosa IsolatesAntibiotic ResistanceSpanish HospitalBacterial PathogensExtended-spectrum β-Lactamases Ges-1	2009	105
OXA-24 Carbapenemase Gene Flanked by XerC/XerD-Like Recombination Sites in Different Plasmids from Different <i>Acinetobacter</i> Species Isolated during a Nosocomial Outbreak María Merino, Joshi Acosta, Margarita Poza, Antimicrobial Agents and Chemotherapy Acinetobacter Calcoaceticus ResistantBacteriologyMolecular BiologyDifferent PlasmidsAntibiotic Resistance	2010	104
A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3) – β – d-glucan chromogenic assay in serum samples Joshi Acosta, M. Catalán, Ángel del Palacio‐Pérez‐Medel, Clinical Microbiology and Infection Diagnostic MycologyMolecular Diagnostic TechniquesProspective ComparisonPathologyLaboratory Medicine	2010	76
Multidrug-Resistant<i>Acinetobacter baumannii</i>Harboring OXA-24 Carbapenemase, Spain Joshi Acosta, María Merino, Esther Viedma, Emerging infectious diseases Antibiotic ResistanceBacterial PathogensDrug ResistanceAntimicrobial StewardshipFebruary 2006	2011	59
Clinical and Molecular Characteristics of Infections with CO <sub>2</sub> -Dependent Small-Colony Variants of <i>Staphylococcus aureus</i> Carmen Gómez-González, Joshi Acosta, Jennifer Villa, Journal of Clinical Microbiology Medical MicrobiologyPathogenic MicrobiologyAntimicrobial Susceptibility-Dependent S. AureusMedicine	2010	47
Prospective study in critically ill non-neutropenic patients: diagnostic potential of (1,3)-β-D-glucan assay and circulating galactomannan for the diagnosis of invasive fungal disease Joshi Acosta, M. Catalán, Ángel del Palacio‐Pérez‐Medel, European Journal of Clinical Microbiology & Infectious Diseases Invasive Fungal DiseaseDiagnostic MycologyDiagnostic PotentialMedicine-β-D-glucan Assay	2011	44
A randomised controlled trial to evaluate a medication monitoring system for TB treatment Joshi Acosta, Paula Vanessa Peclat Flores, MD López Alarcón, The International Journal of Tuberculosis and Lung Disease	2021	39
Multidrug-Resistant<i>Acinetobacter baumannii</i>Harboring OXA-24 Carbapenemase, Spain Joshi Acosta, María Merino, Esther Viedma, Emerging infectious diseases Antibiotic ResistanceBacterial PathogensDrug ResistanceAntimicrobial StewardshipFebruary 2006	2011	11

Page 1